Detalhe da pesquisa
1.
MicroRNA-142 controls thymocyte proliferation.
Eur J Immunol
; 47(7): 1142-1152, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28471480
2.
Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides.
Cancer Immunol Immunother
; 62(4): 715-26, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23184338
3.
Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone.
Blood
; 117(13): 3569-74, 2011 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-21296999
4.
Neutralization of tumor-derived soluble glucocorticoid-induced TNFR-related protein ligand increases NK cell anti-tumor reactivity.
Blood
; 112(9): 3735-43, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18689545
5.
RNA vaccines in cancer treatment.
J Biomed Biotechnol
; 2010: 623687, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20625504
6.
BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells.
Cancer Res
; 67(11): 5489-97, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17545631
7.
Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions.
FASEB J
; 21(10): 2442-54, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17360848
8.
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma.
Exp Hematol Oncol
; 4: 21, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26251761
9.
hDectin-1 is involved in uptake and cross-presentation of cellular antigens.
Blood
; 111(8): 4264-72, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17698636
10.
TLR ligands differentially affect uptake and presentation of cellular antigens.
Blood
; 109(9): 3890-4, 2007 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17218388
11.
Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs.
Blood
; 107(8): 3265-70, 2006 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16380452
12.
PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways.
Blood
; 106(12): 3888-94, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16105976